Recent Progress in Antithrombotic Therapy for Atrial Fibrillation

DOI 被引用文献1件 参考文献107件
  • Velu Selvakumar
    University of Birmingham Centre for Cardiovascular Sciences, City Hospital.
  • Lip Gregory YH
    University of Birmingham Centre for Cardiovascular Sciences, City Hospital.

この論文をさがす

説明

Atrial fibrillation (AF) is becoming a major health care burden as elderly populations increase. The increased risk of stroke and thromboembolisms in patients with AF is well documented and antico-agulation with adjusted-dose warfarin is highly effective in reducing stroke risk, being superior to antiplatelet agents. Despite recognition of the epidemiological problem and the sound evidence base for thromboprophylaxis, as well as major guidelines recommending treatment, anticoagulation use is still suboptimal, given the dis-utility and limitations associated with warfarin. Recent developments in thromboprophylaxis for AF include efforts for better risk stratification for predictions of thromboembolic risk. Constant efforts are underway to develop newer, less cumbersome, alternatives to warfarin with similar (or better) efficacy. This review article provides an overview of the recent progress made, the potential challenges involved and the future of these therapeutic approaches.

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (107)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ